Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Memoli

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Influenza and Other Respiratory Viruses|April 23, 2010
Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virusJohn C Kash, Li Qi, Vivien G Dugan, et al.
Mbio|January 25, 2018
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm VirusJae-Keun Park, Alison Han, Lindsay Czajkowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2013
The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hostsMatthew J Memoli, Rani Athota, Susan Reed, et al.
NPJ Vaccines|April 7, 2021
The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccineLuca T Giurgea, Jae-Keun Park, Kathie-Anne Walters, et al.
Virology|June 22, 2019
Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infectionsYongli Xiao, Jae-Keun Park, Stephanie Williams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug studyMatthew J Memoli, Lindsay Czajkowski, Susan Reed, et al.
Mbio|April 21, 2016
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge ModelMatthew J Memoli, Pamela A Shaw, Alison Han, et al.
Mbio|August 7, 2010
The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymeraseBrett W Jagger, Matthew J Memoli, Zong-Mei Sheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2019
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge ModelAlison Han, Lindsay M Czajkowski, Amanda Donaldson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2020
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Influenza and Other Respiratory Viruses|April 23, 2010
Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virusJohn C Kash, Li Qi, Vivien G Dugan, et al.
Mbio|January 25, 2018
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm VirusJae-Keun Park, Alison Han, Lindsay Czajkowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2013
The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hostsMatthew J Memoli, Rani Athota, Susan Reed, et al.
NPJ Vaccines|April 7, 2021
The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccineLuca T Giurgea, Jae-Keun Park, Kathie-Anne Walters, et al.
Virology|June 22, 2019
Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infectionsYongli Xiao, Jae-Keun Park, Stephanie Williams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug studyMatthew J Memoli, Lindsay Czajkowski, Susan Reed, et al.
Mbio|April 21, 2016
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge ModelMatthew J Memoli, Pamela A Shaw, Alison Han, et al.
Mbio|August 7, 2010
The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymeraseBrett W Jagger, Matthew J Memoli, Zong-Mei Sheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2019
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge ModelAlison Han, Lindsay M Czajkowski, Amanda Donaldson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2020
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Pageof 7